Bandhan BSE Healthcare Index Fund Direct Growth

Fund Overview

Fund Size

₹21 Cr

Expense Ratio

0.36%

ISIN

INF194KB1IS2

Minimum SIP

₹1,000

Exit Load

No Charges

Inception Date

22 Oct 2024

About this fund

Bandhan BSE Healthcare Index Fund Direct Growth is a Index Funds mutual fund schemes offered by Bandhan Mutual Fund. This fund has been in existence for 2 years and 15 days, having been launched on 22-Oct-24.
As of 05-Nov-26, it has a Net Asset Value (NAV) of ₹11.87, Assets Under Management (AUM) of 20.88 Crores, and an expense ratio of 0.36%.

Bandhan BSE Healthcare Index Fund Direct Growth has given a CAGR return of 9.31% since inception.
The fund's asset allocation comprises around 100.15% in equities, 0.00% in debts, and -0.15% in cash & cash equivalents.
You can start investing in Bandhan BSE Healthcare Index Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹1000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+14.86%

— (Cat Avg.)

Since Inception

+9.31%

— (Cat Avg.)

Portfolio Summaryas of 30th September 2026

Equity	₹20.91 Cr	100.15%
Others	₹-0.03 Cr	-0.15%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹2.58 Cr	12.36%
Divi's Laboratories Ltd	Equity	₹1.55 Cr	7.44%
Apollo Hospitals Enterprise Ltd	Equity	₹1.09 Cr	5.23%
Laurus Labs Ltd	Equity	₹1.01 Cr	4.85%
Cipla Ltd	Equity	₹1 Cr	4.80%
Dr Reddy's Laboratories Ltd	Equity	₹0.99 Cr	4.74%
Max Healthcare Institute Ltd Ordinary Shares	Equity	₹0.9 Cr	4.33%
Torrent Pharmaceuticals Ltd	Equity	₹0.74 Cr	3.56%
Lupin Ltd	Equity	₹0.65 Cr	3.11%
Aurobindo Pharma Ltd	Equity	₹0.6 Cr	2.90%
Fortis Healthcare Ltd	Equity	₹0.53 Cr	2.52%
Glenmark Pharmaceuticals Ltd	Equity	₹0.45 Cr	2.17%
Alkem Laboratories Ltd	Equity	₹0.4 Cr	1.90%
Zydus Lifesciences Ltd	Equity	₹0.38 Cr	1.83%
Mankind Pharma Ltd	Equity	₹0.37 Cr	1.76%
Ipca Laboratories Ltd	Equity	₹0.35 Cr	1.69%
Biocon Ltd	Equity	₹0.34 Cr	1.64%
Gland Pharma Ltd	Equity	₹0.3 Cr	1.45%
Sai Life Sciences Ltd	Equity	₹0.27 Cr	1.30%
Krishna Institute of Medical Sciences Ltd	Equity	₹0.26 Cr	1.25%
Aster DM Quality Care Ltd Ordinary Shares	Equity	₹0.25 Cr	1.18%
Neuland Laboratories Ltd	Equity	₹0.24 Cr	1.16%
Wockhardt Ltd	Equity	₹0.23 Cr	1.10%
Acutaas Chemicals Ltd	Equity	₹0.22 Cr	1.06%
Ajanta Pharma Ltd	Equity	₹0.21 Cr	1.02%
Dr. Lal PathLabs Ltd	Equity	₹0.2 Cr	0.96%
Abbott India Ltd	Equity	₹0.18 Cr	0.87%
Piramal Pharma Ltd	Equity	₹0.17 Cr	0.81%
Narayana Hrudayalaya Ltd	Equity	₹0.16 Cr	0.78%
Shilpa Medicare Ltd	Equity	₹0.16 Cr	0.77%
Granules India Ltd	Equity	₹0.16 Cr	0.77%
Global Health Ltd	Equity	₹0.16 Cr	0.76%
OneSource Specialty Pharma Ltd	Equity	₹0.16 Cr	0.75%
GlaxoSmithKline Pharmaceuticals Ltd	Equity	₹0.15 Cr	0.71%
Rubicon Research Ltd	Equity	₹0.14 Cr	0.67%
Anthem Biosciences Ltd	Equity	₹0.12 Cr	0.58%
Jubilant Pharmova Ltd	Equity	₹0.11 Cr	0.52%
Emcure Pharmaceuticals Ltd	Equity	₹0.11 Cr	0.51%
Strides Pharma Science Ltd	Equity	₹0.1 Cr	0.47%
Natco Pharma Ltd	Equity	₹0.1 Cr	0.47%
Cohance Lifesciences Ltd	Equity	₹0.09 Cr	0.45%
Vijaya Diagnostic Centre Ltd	Equity	₹0.09 Cr	0.45%
Net Current Assets	Cash	₹-0.09 Cr	0.44%
Syngene International Ltd	Equity	₹0.09 Cr	0.44%
Marksans Pharma Ltd	Equity	₹0.09 Cr	0.43%
Rainbow Childrens Medicare Ltd	Equity	₹0.09 Cr	0.42%
Poly Medicure Ltd	Equity	₹0.08 Cr	0.40%
Indegene Ltd	Equity	₹0.08 Cr	0.38%
Eris Lifesciences Ltd Registered Shs	Equity	₹0.08 Cr	0.38%
Pfizer Ltd	Equity	₹0.08 Cr	0.37%
Metropolis Healthcare Ltd	Equity	₹0.08 Cr	0.36%
Caplin Point Laboratories Ltd	Equity	₹0.07 Cr	0.34%
Aarti Pharmalabs Ltd	Equity	₹0.06 Cr	0.31%
Jupiter Life Line Hospitals Ltd	Equity	₹0.06 Cr	0.30%
Concord Biotech Ltd	Equity	₹0.06 Cr	0.29%
Bliss GVS Pharma Ltd	Equity	₹0.06 Cr	0.29%
Alembic Pharmaceuticals Ltd	Equity	₹0.06 Cr	0.29%
Triparty Repo Trp_011026	Cash - Repurchase Agreement	₹0.06 Cr	0.28%
Procter & Gamble Health Ltd	Equity	₹0.06 Cr	0.28%
Yatharth Hospital and Trauma Care Services Ltd	Equity	₹0.06 Cr	0.28%
Morepen Laboratories Ltd	Equity	₹0.06 Cr	0.27%
Alivus Life Sciences Ltd	Equity	₹0.06 Cr	0.27%
Corona Remedies Ltd	Equity	₹0.05 Cr	0.25%
AstraZeneca Pharma India Ltd	Equity	₹0.05 Cr	0.24%
Viyash Scientific Ltd	Equity	₹0.05 Cr	0.23%
Dr Agarwal’s Health Care Ltd	Equity	₹0.05 Cr	0.23%
HealthCare Global Enterprises Ltd	Equity	₹0.05 Cr	0.22%
Senores Pharmaceuticals Ltd	Equity	₹0.05 Cr	0.22%
Thyrocare Technologies Ltd	Equity	₹0.04 Cr	0.21%
Akums Drugs and Pharmaceuticals Ltd	Equity	₹0.04 Cr	0.18%
Kovai Medical Center & Hospital Ltd	Equity	₹0.04 Cr	0.17%
Sanofi India Ltd	Equity	₹0.04 Cr	0.17%
Sanofi Consumer Healthcare India Ltd	Equity	₹0.03 Cr	0.16%
Supriya Lifescience Ltd	Equity	₹0.03 Cr	0.15%
Nephrocare Health Services Ltd	Equity	₹0.03 Cr	0.15%
Suven Life Sciences Ltd	Equity	₹0.03 Cr	0.15%
IOL Chemicals And Pharmaceuticals Ltd	Equity	₹0.03 Cr	0.15%
Blue Jet Healthcare Ltd	Equity	₹0.03 Cr	0.13%
Park Medi World Ltd	Equity	₹0.03 Cr	0.13%
Ind-Swift Laboratories Ltd	Equity	₹0.02 Cr	0.12%
Sun Pharma Advanced Research Co Ltd	Equity	₹0.02 Cr	0.12%
Innova Captab Ltd	Equity	₹0.02 Cr	0.12%
Solara Active Pharma Sciences Ltd Ordinary Shares	Equity	₹0.02 Cr	0.11%
Artemis Medicare Services Ltd Ordinary Shares	Equity	₹0.02 Cr	0.11%
FDC Ltd	Equity	₹0.02 Cr	0.10%
Kwality Pharmaceuticals Ltd	Equity	₹0.02 Cr	0.10%
Indraprastha Medical Corp Ltd	Equity	₹0.02 Cr	0.10%
Aarti Drugs Ltd	Equity	₹0.02 Cr	0.10%
Orchid Pharma Ltd	Equity	₹0.02 Cr	0.10%
SMS Pharmaceuticals Ltd	Equity	₹0.02 Cr	0.09%
Evonile Pharma Ltd	Equity	₹0.02 Cr	0.09%
Venus Remedies Ltd	Equity	₹0.02 Cr	0.09%
Shukra Pharmaceuticals Ltd	Equity	₹0.02 Cr	0.08%
Advanced Enzyme Technologies Ltd	Equity	₹0.02 Cr	0.08%
RPG Life Sciences Ltd	Equity	₹0.02 Cr	0.08%
Gujarat Themis Biosyn Ltd	Equity	₹0.02 Cr	0.08%
Gufic Biosciences Ltd	Equity	₹0.02 Cr	0.07%
Syncom Formulation (India) Ltd	Equity	₹0.02 Cr	0.07%
Unichem Laboratories Ltd	Equity	₹0.01 Cr	0.07%
Krsnaa Diagnostics Ltd	Equity	₹0.01 Cr	0.06%
Dishman Carbogen Amics Ltd	Equity	₹0.01 Cr	0.06%
Fredun Pharmaceuticals Ltd	Equity	₹0.01 Cr	0.06%
Indoco Remedies Ltd	Equity	₹0.01 Cr	0.06%
Vimta Labs Ltd	Equity	₹0.01 Cr	0.06%
Anlon Healthcare Ltd	Equity	₹0.01 Cr	0.05%
3B BlackBio Dx Ltd	Equity	₹0.01 Cr	0.05%
Windlas Biotech Ltd	Equity	₹0.01 Cr	0.05%
Fischer Medical Ventures Ltd	Equity	₹0.01 Cr	0.05%
Hester Biosciences Ltd	Equity	₹0.01 Cr	0.05%
Hikal Ltd	Equity	₹0.01 Cr	0.05%
Amrutanjan Health Care Ltd	Equity	₹0.01 Cr	0.05%
Kopran Ltd	Equity	₹0.01 Cr	0.05%
Suraksha Diagnostic Ltd	Equity	₹0.01 Cr	0.04%
Sigachi Industries Ltd	Equity	₹0.01 Cr	0.04%
KMC Speciality Hospitals (India) Ltd	Equity	₹0.01 Cr	0.04%
Sai Parenteral's Ltd	Equity	₹0.01 Cr	0.04%
Dr Agarwal'S Eye Hospital Ltd	Equity	₹0.01 Cr	0.04%
Panacea Biotec Ltd	Equity	₹0.01 Cr	0.04%
Lincoln Pharmaceuticals Ltd	Equity	₹0.01 Cr	0.04%
Fermenta Biotech Ltd	Equity	₹0.01 Cr	0.03%
Tarsons Products Ltd	Equity	₹0.01 Cr	0.03%
NGL Fine-Chem Ltd	Equity	₹0.01 Cr	0.03%
Bajaj Healthcare Ltd	Equity	₹0.01 Cr	0.03%
GPT Healthcare Ltd	Equity	₹0.01 Cr	0.03%
Jagsonpal Pharmaceuticals Ltd	Equity	₹0.01 Cr	0.03%
Gujarat Kidney And Super Speciality Ltd	Equity	₹0.01 Cr	0.02%
Wanbury Ltd	Equity	₹0.01 Cr	0.02%
Shalby Ltd	Equity	₹0 Cr	0.02%
Laxmi Dental Ltd	Equity	₹0 Cr	0.02%
Themis Medicare Ltd	Equity	₹0 Cr	0.02%
One Global Service Provider Ltd	Equity	₹0 Cr	0.02%
Kilitch Drugs (India) Ltd	Equity	₹0 Cr	0.02%
Medicamen Biotech Ltd	Equity	₹0 Cr	0.02%
Anuh Pharma Ltd Shs Dematerialised	Equity	₹0 Cr	0.02%
Gaudium IVF And Women Health Ltd	Equity	₹0 Cr	0.01%
Ambalal Sarabhai Enterprises Ltd	Equity	₹0 Cr	0.01%
Fabtech Technologies Ltd	Equity	₹0 Cr	0.01%
Take Ltd	Equity	₹0 Cr	0.01%
Gennex Laboratories Ltd	Equity	₹0 Cr	0.01%
Medico Remedies Ltd Ordinary Shares	Equity	₹0 Cr	0.00%
Cash Margin - Ccil	Cash - Repurchase Agreement	₹0 Cr	0.00%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹20.67 Cr	99.00%
Basic Materials	₹0.24 Cr	1.15%

Risk & Performance Ratios

Fund Managers

Abhishek Jain

Since March 2025

Mayuresh Nagvekar

Since February 2026

Additional Scheme Detailsas of 30th September 2026

ISIN

INF194KB1IS2

Expense Ratio

0.36%

Exit Load

No Charges

Fund Size

₹21 Cr

Age

2 years

Lumpsum Minimum

₹1,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Index Funds Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Kotak Nifty Realty Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Realty Index Fund Direct Growth Very High Risk	-	0.0%	-	-
UTI Nifty India New Age Consumption Index Fund Regular Growth Very High Risk	-	0.0%	-	-
UTI Nifty India New Age Consumption Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Axis Nifty EV & New Age Automotive Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Axis Nifty EV & New Age Automotive Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty Midcap 150 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 100 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty Midcap 150 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty 100 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Quant Nifty 50 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Quant Nifty 50 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Motilal Oswal Nifty Midcap150 Plus 8-13 yr G-Sec 70:30 Index Fund Direct Growth Very High Risk	-	1.0%	-	-
Motilal Oswal Nifty Midcap150 Plus 8-13 yr G-Sec 70:30 Index Fund Regular Growth Very High Risk	-	1.0%	-	-
Kotak Nifty 500 Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market ETF Very High Risk	-	-	-	-
HDFC Nifty LargeMidcap250 Plus 8-13 yr G-sec 70 30 Index Fund Regular Growth High Risk	-	0.0%	-	-
HDFC Nifty LargeMidcap250 Plus 8-13 yr G-sec 70 30 Index Fund Direct Growth High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Aditya Birla Sun Life BSE Total Market Index Fund Direct Growth Very High Risk	-	0.0%	-	-
HDFC FTSE India Equity ETF Very High Risk	-	-	-	-
Motilal Oswal Nifty REITs & Realty Index Fund Regular Growth Very High Risk	-	1.0%	-	-
Motilal Oswal Nifty REITs & Realty Index Fund Direct Growth Very High Risk	-	1.0%	-	-
Zerodha Nifty Next 100 ETF Very High Risk	-	-	-	-
HDFC BSE REITS and Commercial Real Estate Index Fund Regular Growth Very High Risk	1.0%	0.0%	₹32.03 Cr	-
HDFC BSE REITS and Commercial Real Estate Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹32.03 Cr	-
Kotak Nifty Capital Markets Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Kotak Nifty Capital Markets Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Invesco India Nifty Chemical Index Fund Direct Growth Very High Risk	-	0.0%	-	-
Axis Nifty500 Low Volatility 50 Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹29.13 Cr	-
Axis Nifty500 Low Volatility 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹29.13 Cr	-
Invesco India Nifty Chemical Index Fund Regular Growth Very High Risk	-	0.0%	-	-
Mirae Asset BSE Information Technology Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹10.60 Cr	-
Mirae Asset BSE Information Technology Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹10.60 Cr	-
Navi Nifty REITs & Realty Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹16.02 Cr	-
Navi Nifty REITs & Realty Index Fund Regular Growth Very High Risk	1.1%	0.0%	₹16.02 Cr	-
UTI BSE India Sector Leaders Index Fund Regular Growth Very High Risk	1.1%	0.0%	-	-
UTI BSE India Sector Leaders Index Fund Direct Growth Very High Risk	0.2%	0.0%	-	-
UTI BSE India Sector Leaders Exchange Traded Fund Very High Risk	0.2%	-	₹7.15 Cr	-
JioBlackRock Nifty Next 50 Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹220.42 Cr	-
JioBlackRock Nifty 50 Index Fund Regular Growth Very High Risk	0.5%	0.0%	₹264.38 Cr	-
JioBlackRock Nifty Midcap 150 Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹266.42 Cr	-
JioBlackRock Nifty Smallcap 250 Index Fund Regular Growth Very High Risk	0.9%	0.0%	₹392.92 Cr	-
Mirae Asset BSE LargeMid (60 40) Stable Dividend 50 ETF Very High Risk	3.6%	-	₹22.29 Cr	-
UTI Nifty 500 Index Fund Direct Growth Very High Risk	-	0.0%	₹101.72 Cr	-
UTI Nifty 500 Index Fund Regular Growth Very High Risk	-	0.0%	₹101.72 Cr	-
Axis Nifty Energy Index Fund Regular Growth Very High Risk	10.2%	0.0%	₹89.24 Cr	-
Axis Nifty Energy Index Fund Direct Growth Very High Risk	9.4%	0.0%	₹89.24 Cr	-
JioBlackRock Nifty 50 ETF Very High Risk	2.7%	-	₹76.58 Cr	-

About the AMC

Bandhan Mutual Fund

022-66289999

https://bandhanmutual.com/

Total AUM

₹2,17,091 Cr

Address

6th Floor, 841, One World Center, Mumbai, 400013

Other Funds by Bandhan Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Bandhan Contra Fund Direct Growth Very High Risk	5.6%	0.0%	₹1711.91 Cr	-
Arudha Equity Long-Short Fund Direct Growth High Risk	1.7%	0.0%	₹133.38 Cr	-
Bandhan Gold ETF FOF Direct Growth High Risk	0.1%	0.0%	₹164.35 Cr	-
Bandhan Silver ETF FOF Direct Growth Very High Risk	0.1%	0.0%	₹154.62 Cr	-
Arudha Hybrid Long-Short Fund Direct Growth Low Risk	0.8%	0.0%	₹157.80 Cr	-
Bandhan Healthcare Fund Direct Growth Very High Risk	1.3%	0.0%	₹326.54 Cr	-
Bandhan BSE India Sector Leaders Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹22.62 Cr	-3.3%
Bandhan Multi-Factor Fund Direct Growth Very High Risk	2.6%	0.0%	₹588.23 Cr	-6.5%
Bandhan CRISIL-IBX Financial Services 3-6 Months Debt Index Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹386.66 Cr	6.8%
Bandhan CRISIL-IBX 10:90 Gilt + SDL Index - Dec 2029 Fund Direct Growth Low to Moderate Risk	0.0%	0.0%	₹0.35 Cr	5.6%
Bandhan Nifty Next 50 Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹34.82 Cr	2.9%
Bandhan Fixed Maturity Plan (FMP) - Series 209 (93 Days) Direct Growth Low to Moderate Risk	-	0.0%	-	-
Bandhan Nifty Alpha Low Volatility 30 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹9.18 Cr	-2.3%
Bandhan Nifty 200 Quality 30 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹13.28 Cr	-4.2%
Bandhan Nifty 500 Momentum 50 Index Fund Direct Growth Very High Risk	0.9%	0.0%	₹37.21 Cr	-1.4%
Bandhan Nifty 500 Value 50 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹38.85 Cr	2.8%
Bandhan Business Cycle Fund Direct Growth Very High Risk	1.0%	0.0%	₹1002.60 Cr	-2.9%
Bandhan Nifty Midcap 150 Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹87.49 Cr	0.8%
Bandhan BSE Healthcare Index Fund Direct Growth Very High Risk	0.4%	0.0%	₹20.88 Cr	14.9%
Bandhan Nifty Bank Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹19.28 Cr	0.2%
Bandhan Nifty Total Market Index Fund Direct Growth Very High Risk	0.7%	0.0%	₹42.28 Cr	-1.3%
Bandhan Innovation Fund Direct Growth Very High Risk	0.9%	0.0%	₹3085.41 Cr	16.2%
Bandhan Long Duration Fund Direct Growth Moderate Risk	0.3%	0.0%	₹46.24 Cr	4.2%
Bandhan Multi Asset Allocation Fund Direct Growth Very High Risk	0.8%	0.0%	₹3684.26 Cr	7.4%
Bandhan Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹105.99 Cr	1.3%
Bandhan Nifty Alpha 50 Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹598.04 Cr	3.3%
Bandhan Retirement Fund Direct Growth Moderately High risk	1.0%	0.0%	₹174.49 Cr	1.5%
Bandhan Nifty IT Index Fund Direct Growth Very High Risk	0.6%	0.0%	₹31.68 Cr	-5.9%
Bandhan Interval Fund - Series 17 Direct Growth Moderate Risk	-	0.0%	-	-
Bandhan Fixed Term Plan Series 197 Direct Growth Moderate Risk	-	0.0%	-	-
Bandhan Fixed Term Plan Series 179 Direct Growth Low to Moderate Risk	-	0.0%	₹334.47 Cr	4.9%
Bandhan Overnight Fund Direct Growth Low Risk	0.1%	0.0%	₹1213.38 Cr	5.3%
Bandhan Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹16269.40 Cr	6.5%
Bandhan Core Equity Fund Direct Growth Very High Risk	1.2%	1.0%	₹20650.23 Cr	1.2%
Bandhan Dynamic Bond Fund Direct Growth Moderate Risk	0.8%	0.0%	₹1909.92 Cr	6.8%
Bandhan Large Cap Fund Direct Growth Very High Risk	1.1%	0.0%	₹2097.65 Cr	1.6%
Bandhan Asset Allocation FOF Aggressive Plan Direct Growth Very High Risk	0.1%	1.0%	₹21.99 Cr	3.8%
Bandhan Government Securities Fund Investment Plan Direct Growth Moderate Risk	0.6%	0.0%	₹1686.14 Cr	7.4%
Bandhan Focused Equity Fund Direct Growth Very High Risk	1.0%	1.0%	₹2086.88 Cr	2.0%
Bandhan Government Securities Fund - Constant Maturity Plan Direct Growth Moderate Risk	0.3%	0.0%	₹285.02 Cr	4.3%
Bandhan Infrastructure Fund Direct Growth Very High Risk	1.1%	0.0%	₹1393.16 Cr	-3.2%
Bandhan Regular Savings Fund Direct Growth Moderately High risk	0.9%	0.0%	₹85.56 Cr	3.8%
Bandhan Bond Fund - Medium Term Plan Direct Growth Moderate Risk	0.7%	0.0%	₹1244.08 Cr	5.5%
Bandhan Bond Fund - Income Plan Direct Growth Moderate Risk	1.0%	1.0%	₹427.78 Cr	5.4%
Bandhan Money Manager Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹13128.61 Cr	6.5%
Bandhan Bond Fund - Short Term Plan Direct Growth Moderate Risk	0.4%	0.0%	₹8680.22 Cr	5.7%
Bandhan Nifty 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹2671.45 Cr	-3.3%
Bandhan Sterling Value Fund Direct Growth Very High Risk	1.0%	1.0%	₹9507.22 Cr	0.2%
Bandhan Flexi Cap Fund Direct Growth Very High Risk	1.5%	1.0%	₹7115.19 Cr	0.5%
Bandhan Crisil IBX Gilt November 2026 Index Fund Direct Growth Low Risk	0.1%	0.0%	₹89.99 Cr	5.7%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Dezerv

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Bandhan BSE Healthcare Index Fund Direct Growth?

The NAV of Bandhan BSE Healthcare Index Fund Direct Growth, as of 05-Nov-2026, is ₹11.87.

What is the portfolio composition of Bandhan BSE Healthcare Index Fund Direct Growth?

The fund's allocation of assets is distributed as 100.15% in equities, 0.00% in bonds, and -0.15% in cash and cash equivalents.

Who manages the Bandhan BSE Healthcare Index Fund Direct Growth?

The fund managers responsible for Bandhan BSE Healthcare Index Fund Direct Growth are:-

Abhishek Jain
Mayuresh Nagvekar

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

©2021-2026 Dezerv. All Rights Reserved

Dezerv Investments Pvt. Ltd. is a Portfolio Manager with SEBI Registration no. INP000007377, a member of BSE with SEBI Stock Broker Registration no. INZ000303136, and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.

Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.

Bandhan BSE Healthcare Index Fund Direct Growth

Fund Overview